Caris entered a new financing agreement with Blue Owl Capital on April 1, 2026, providing up to $400M in capital.
Filing excerpt
On April 1, 2026, we entered into a new financing agreement (the “2026 Financing Agreement”) with the lenders party thereto and Blue Owl Capital Corporation... for an aggregate principal amount of up to $400.0 million...
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-10qdigitalTransformationGet every 10-Q signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/a6c4ba73-4f14-445b-8fd5-7899d3373001 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "a6c4ba73-4f14-445b-8fd5-7899d3373001",
"signal_type": "sec-10q",
"signal_subtype": "digitalTransformation",
"detected_at": "2026-05-12T09:24:55.987+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "Caris entered a new financing agreement with Blue Owl Capital on April 1, 2026, providing up to $400M in capital. These funds are earmarked for key growth activities, including building out laboratories and commercial expansion, indicating significant budget for new equipment, technology, and operational systems in 2026.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "new financing agreement for aggregate principal amount",
"dollar_millions": 400
},
"summary": "Secured new $400M financing agreement to fund CapEx, R&D, and commercial expansion",
"excerpts": "On April 1, 2026, we entered into a new financing agreement (the “2026 Financing Agreement”) with the lenders party thereto and Blue Owl Capital Corporation... for an aggregate principal amount of up to $400.0 million...",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000044/cai-20260331.htm",
"filing_date": "2026-05-08",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Multi-year tech investment",
"signal_category": "strategic",
"vendors_mentioned": [
"Blue Owl Capital Corporation"
]
}
}
curl https://signals.autobound.ai/v1/signals/a6c4ba73-4f14-445b-8fd5-7899d3373001 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.